Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative analgesia after elective hip surgery - effect of obturator nerve blockade
2017-000068-14Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bupivacaine in postoperative pain, sponsored by Aarhus University. Primary endpoint: Cumulated opioid dose 0-12 hours after total hip replacement. Started Apr 2017; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2017-000068-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000068-14.